封面
市場調查報告書
商品編碼
1625428

鴉片類藥物市場、規模、佔有率、趨勢、行業分析報告(按類別、產品、發佈類型、應用和地區)- 市場預測,2025-2034 年

Opioid Market Size, Share, Trends, Industry Analysis Report: By Class, Product, Release Type, Application, and Region - Market Forecast, 2025-2034

出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究,全球鴉片類藥物市場預計到 2034 年將達到 284.5 億美元。該報告提供了有關當前市場動態的詳細見解,並對未來市場的成長進行了分析。

鴉片類藥物市場的成長得益於公司之間合作關係的增加。製藥公司、醫療保健提供者和研究機構之間的合作正在促進鴉片類藥物治療新配方和改進輸送系統的開發。這些聯盟使公司能夠整合資源、利用專業知識並加快研發進程,有助於更快地將有效的疼痛管理解決方案推向市場。此外,策略合作夥伴關係將改善分銷網絡並擴大鴉片類藥物的獲取管道,特別是在服務不足的地區。攜手應對與鴉片類藥物處方相關的課題,包括安全問題和法規遵從性,將促進更全面的疼痛管理方法,並最終減少鴉片類藥物在市場上的佔有率。

由於需要有效的疼痛管理,創傷性損傷的發生率不斷上升是鴉片類藥物市場需求的主要驅動力。美國每年報告約 150 萬例創傷性腦損傷病例,其中許多需要住院和長期疼痛管理。疾病預防控制中心強調,在這些情況下,疼痛管理對於康復至關重要,這增加了對鴉片類藥物的需求。此外,人們對創傷性腦損傷的長期影響的認識不斷提高,凸顯了全面疼痛策略的必要性,預計這將促使鴉片類藥物處方進一步增加。因此,預計未來幾年鴉片類藥物市場規模將會擴大。

由於人們對疼痛管理的認識和教育不斷提高,鴉片類藥物市場正在擴大。患者和醫療保健提供者都越來越意識到可以選擇的各種治療方案。美國約有 5000 萬成年人患有慢性疼痛。更新的醫療指南使醫生在開立鴉片類藥物時更有信心,並確保它們被適當地用於疼痛管理。人們對疼痛治療方案的瞭解不斷加深,促進了鴉片類藥物在慢性疼痛管理中使用的增加。

鴉片類藥物市場報告重點

根據釋放類型,預計在預測期內,全球市場上延長/長效鴉片類藥物部分將以顯著的複合年增長率增長。這種增長是由於需要長效鴉片類藥物治療的長期疼痛和損傷的盛行率不斷上升所推動的。

根據應用,由於慢性和急性損傷的增加,疼痛管​​理領域預計將在 2024 年佔據市場最大的收入佔有率。

由於醫院數量的增加促使處方率上升,北美將在 2024 年佔據全球鴉片類藥物市場的主導佔有率。

由於資本籌集和外國直接投資流入的增加,印度鴉片類藥物市場預計將大幅成長。

全球市場的主要參與者包括 Aurobindo Pharma Limited;Assertio Therapeutics, Inc.;AbbVie Inc.;Actavis Plc.;Amneal Pharmaceuticals LLC;Boehringer Ingelheim International GmbH;Cadila Healthcare Limited;Fresenius Kabi;Mallinckrodt Pharmaceutical International GmbH;Cadila Healthcare Limited;Fresenius Kabilcuticals's Pharmaceuticals;Endolcuticals;Endolcuticals plcuticals; ;強生公司;Lupin Limited;Nesher Pharmaceuticals LLC;普渡製藥有限公司;輝瑞公司;Rhodes Pharmaceuticals L.P.;太陽製藥工業有限公司;Trevena Inc.;和Teva Pharmaceutical Industries Ltd.

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章 研究方法

第 4 章全球鴉片類藥物市場洞察

  • 市場概況
  • 鴉片類藥物市場動態
    • 推動因素和機遇
      • 創傷性損傷的增加推動了市場擴張
      • 加大對醫療基礎設施的投資將推動市場成長
    • 阻礙因素和課題
      • 嚴格的政府法規
  • PESTEL 分析
  • 鴉片類藥物市場趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第 5 章全球鴉片類藥物市場分類
  • 主要發現
  • 簡介
  • 自然
  • 半合成
  • 全合成

第6章 全球鴉片類藥物市場(依產品劃分)

  • 主要發現
  • 簡介
  • 可待因
  • 芬太尼
  • 羥可酮
  • 美沙酮
  • 嗎啡
  • 氫可酮
  • 曲馬多
  • 丙氧芬
  • 其他

第7章 全球鴉片類藥物市場依釋放類型劃分

  • 主要發現
  • 簡介
  • 速效/短效鴉片類藥物
  • 緩釋/長效型鴉片類藥物

第 8 章全球鴉片類藥物市場(按應用)
  • 主要發現
  • 簡介
  • 疼痛管理
  • 癌症疼痛
  • 治療咳嗽
  • 止痛藥
  • 治療腹瀉
  • 擺脫毒癮
  • 其他

第 9 章全球鴉片類藥物市場按區域劃分
  • 主要發現
  • 簡介
      鴉片類藥物市場評估:各地區,2020 年至 2034 年
  • 北美洲
    • 北美:依類別,2020 年至 2034 年 2020 至 2034 年北美各產品狀況
    • 2020 年至 2034 年,北美依排放類型劃分
    • 2020 年至 2034 年北美各應用領域
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:依類別,2020 年至 2034 年 歐洲,依產品分類,2020-2034 年
    • 歐洲:依排放類型,2020 年至 2034 年 2020 年至 2034 年歐洲應用狀況
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
    亞太地區
      2020 年至 2034 年亞太地區各類別 2020 年至 2034 年亞太地區產品分佈 2020 年至 2034 年亞太地區排放類型 2020 年至 2034 年亞太地區應用狀況
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
    • 中東和非洲:依類別,2020 年至 2034 年 中東和非洲:依產品分類,2020 年至 2034 年 中東和非洲:依排放類型,2020 年至 2034 年 2020 年至 2034 年中東和非洲的應用狀況
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 2020 年至 2034 年拉丁美洲各類別 2020 年至 2034 年拉丁美洲各產品
    • 2020 年至 2034 年拉丁美洲依排放類型劃分
    • 2020 年至 2034 年拉丁美洲各應用領域狀況
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第 10 章 競爭格局

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協定/揭露

第 11 章 公司簡介

  • Aurobindo Pharma Limited
  • Assertio Therapeutics, Inc.
  • AbbVie Inc.
  • Actavis Plc.
  • Amneal Pharmaceuticals LLC
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Limited
  • Fresenius Kabi
  • Mallinckrodt Pharmaceuticals
  • Endo International plc
  • Johnson & Johnson Corporation
  • Lupin Limited
  • Nesher Pharmaceuticals LLC
  • Purdue Pharma L.P.
  • Pfizer Inc.
  • Rhodes Pharmaceuticals L.P.
  • Sun Pharmaceutical Industries Limited
  • Trevena Inc.
  • Teva Pharmaceutical Industries Ltd.
Product Code: PM1368

The global opioid market size is expected to reach USD 28.45 billion by 2034, according to a new study by Polaris Market Research. The report "Opioid Market Size, Share, Trends, Industry Analysis Report: By Class, Product, Release Type (Immediate-Release/Short-Acting Opioid and Extended-Release/Long-Acting Opioid), Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The opioid market growth is attributed to an increase in partnerships between companies. Collaborations between pharmaceutical firms, healthcare providers, and research institutions are facilitating the development of new formulations and improved delivery systems for opioid therapies. These alliances enable organizations to combine resources, leverage expertise, and expedite the research and development process, allowing for faster introduction of effective pain management solutions to the market. Additionally, strategic partnerships improve distribution networks and expand access to opioid medications, particularly in underserved areas. Companies join forces to address challenges related to opioid prescribing such as safety concerns and regulatory compliance; they are promoting a more holistic approach to pain management, ultimately strengthening the presence of opioids in the market.

The rising prevalence of traumatic injuries significantly drives opioid market demand due to the need for effective pain management. The US reports around 1.5 million traumatic brain injury cases annually, with many requiring hospitalization and long-term pain management. The CDC highlights that pain management is essential for recovery in these cases, increasing the demand for opioids. Additionally, heightened awareness of the long-term effects of TBIs emphasizes the necessity for comprehensive pain strategies, further leading to an expected rise in opioid prescriptions. Consequently, the opioid market size is poised for growth in the projected years.

The opioid market is expanding due to increased awareness and education about pain management. Both patients and healthcare providers are learning more about the different treatment options available. In the United States, nearly 50 million adults suffer from chronic pain. Updated medical guidelines are helping doctors feel more confident when prescribing opioids, ensuring they are used properly to manage pain. This growing understanding of pain treatment options is contributing to the rise in the use of opioids for managing chronic pain.

Opioid Market Report Highlights

By release type, the extended-release/long-acting opioid segment is anticipated to experience substantial growth at a significant CAGR in the global market during the forecast period. This growth is attributed to an increase in the prevalence of extended pain and traumatic injuries requiring long-acting opioids.

The pain management segment, by application, accounted for the largest revenue share of the market in 2024 due to the rising number of chronic and acute injuries.

In 2024, North America dominated the global opioid market share due to the increasing number hospitals, leading to the increase in prescription rate.

The opioid market in India is projected for substantial growth due to the increasing funding and foreign direct investment inflow.

A few global key market players are Aurobindo Pharma Limited; Assertio Therapeutics, Inc.; AbbVie Inc.; Actavis Plc.; Amneal Pharmaceuticals LLC; Boehringer Ingelheim International GmbH; Cadila Healthcare Limited; Fresenius Kabi; Mallinckrodt Pharmaceuticals; Endo International plc; Johnson & Johnson Corporation; Lupin Limited; Nesher Pharmaceuticals LLC; Purdue Pharma L.P.; Pfizer Inc.; Rhodes Pharmaceuticals L.P.; Sun Pharmaceutical Industries Limited; Trevena Inc.; Teva Pharmaceutical Industries Ltd.

Polaris Market Research has segmented the opioid market report on the basis of class, product, release type, application, and region:

By Class Outlook (Revenue - USD Billion, 2020-2034)

  • § Natural
  • § Semi-Synthetic
  • § Fully Synthetic

By Product Outlook (Revenue - USD Billion, 2020-2034)

  • § Codeine
  • § Fentanyl
  • § Oxycodone
  • § Methadone
  • § Morphine
  • § Hydrocodone
  • § Tramadol
  • § Propoxyphene
  • § Others

By Release Type Outlook (Revenue - USD Billion, 2020-2034)

  • § Immediate-Release/Short-Acting Opioid
  • § Extended-Release/Long-Acting Opioid
  • By Application (Revenue - USD Billion, 2020-2034)
  • § Pain Management
  • § Neuropathic
  • § Migraine
  • § Orthopedic and Musculoskeletal
  • § Arthritis
  • § Fibromyalgia
  • § Others
  • § Cancer Pain
  • § Brain
  • § Breast
  • § Colorectal
  • § Blood
  • § Skin
  • § Prostate
  • § Others
  • § Cough Treatment
  • § Analgesia
  • § Diarrhea Treatment
  • § De-addiction
  • § Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Opioid Market Insights

  • 4.1. Opioid Market - Market Snapshot
  • 4.2. Opioid Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Traumatic Injuries is Driving the Market Size
      • 4.2.1.2. Increasing Investment for Expansion of Medical Infrastructure Are Driving the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent Government Regulation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Opioid Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Opioid Market, by Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Opioid Market, by Class, 2020-2034 (USD billion)
  • 5.3. Natural
    • 5.3.1. Global Opioid Market, by Natural, by Region, 2020-2034 (USD billion)
  • 5.4. Semi-synthetic
    • 5.4.1. Global Opioid Market, by Semi-synthetic, by Region, 2020-2034 (USD billion)
  • 5.5. Fully synthetic
    • 5.5.1. Global Opioid Market, by Fully synthetic, by Region, 2020-2034 (USD billion)

6. Global Opioid Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Opioid Market, by Product, 2020-2034 (USD billion)
  • 6.3. Codeine
    • 6.3.1. Global Opioid Market, by Codeine, by Region, 2020-2034 (USD billion)
  • 6.4. Fentanyl
    • 6.4.1. Global Opioid Market, by Fentanyl, by Region, 2020-2034 (USD billion)
  • 6.5. Oxycodone
    • 6.5.1. Global Opioid Market, by Oxycodone, by Region, 2020-2034 (USD billion)
  • 6.6. Methadone
    • 6.6.1. Global Opioid Market, by Methadone, by Region, 2020-2034 (USD billion)
  • 6.7. Morphine
    • 6.7.1. Global Opioid Market, by Morphine, by Region, 2020-2034 (USD billion)
  • 6.8. Hydrocodone
    • 6.8.1. Global Opioid Market, by Hydrocodone, by Region, 2020-2034 (USD billion)
  • 6.9. Tramadol
    • 6.9.1. Global Opioid Market, by Tramadol, by Region, 2020-2034 (USD billion)
  • 6.10. Propoxyphene
    • 6.10.1. Global Opioid Market, by Propoxyphene, by Region, 2020-2034 (USD billion)
  • 6.11. Others
    • 6.11.1. Global Opioid Market, by Others, by Region, 2020-2034 (USD billion)

7. Global Opioid Market, by Release Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Opioid Market, by Release Type, 2020-2034 (USD billion)
  • 7.3. Immediate-release/Short-acting opioid
    • 7.3.1. Global Opioid Market, by Immediate-release/Short-acting opioid by Region, 2020-2034 (USD billion)
  • 7.4. Extended-release/Long-acting opioid
    • 7.4.1. Global Opioid Market, by Extended-release/Long-acting opioid, by Region, 2020-2034 (USD billion)

8. Global Opioid Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Opioid Market, by Application, 2020-2034 (USD billion)
  • 8.3. Pain Management
    • 8.3.1. Global Opioid Market, by Pain Management, by Region, 2020-2034 (USD billion)
    • 8.3.2. Neuropathic
      • 8.3.2.1. Global Opioid Market, by Neuropathic, by Region, 2020-2034 (USD billion)
    • 8.3.3. Migraine
      • 8.3.3.1. Global Opioid Market, by Migraine, by Region, 2020-2034 (USD billion)
    • 8.3.4. Orthopedic and Musculoskeletal
      • 8.3.4.1. Global Opioid Market, by Orthopedic and Musculoskeletal, by Region, 2020-2034 (USD billion)
    • 8.3.5. Arthritis
      • 8.3.5.1. Global Opioid Market, by Arthritis, by Region, 2020-2034 (USD billion)
    • 8.3.6. Fibromyalgia
      • 8.3.6.1. Global Opioid Market, by Fibromyalgia, by Region, 2020-2034 (USD billion)
    • 8.3.7. Others
      • 8.3.7.1. Global Opioid Market, by Others, by Region, 2020-2034 (USD billion)
  • 8.4. Cancer Pain
    • 8.4.1. Global Opioid Market, by Cancer Pain, by Region, 2020-2034 (USD billion)
    • 8.4.2. Brain
      • 8.4.2.1. Global Opioid Market, by Brain, by Region, 2020-2034 (USD billion)
    • 8.4.3. Breast
      • 8.4.3.1. Global Opioid Market, by Breast, by Region, 2020-2034 (USD billion)
    • 8.4.4. Colorectal
      • 8.4.4.1. Global Opioid Market, by Colorectal, by Region, 2020-2034 (USD billion)
    • 8.4.5. Blood
      • 8.4.5.1. Global Opioid Market, by Blood, by Region, 2020-2034 (USD billion)
    • 8.4.6. Skin
      • 8.4.6.1. Global Opioid Market, by Skin, by Region, 2020-2034 (USD billion)
    • 8.4.7. Prostate
      • 8.4.7.1. Global Opioid Market, by Prostate, by Region, 2020-2034 (USD billion)
    • 8.4.8. Others
      • 8.4.8.1. Global Opioid Market, by Others, by Region, 2020-2034 (USD billion)
  • 8.5. Cough treatment
    • 8.5.1. Global Opioid Market, by Cough treatment, by Region, 2020-2034 (USD billion)
  • 8.6. Analgesia
    • 8.6.1. Global Opioid Market, by Analgesia, by Region, 2020-2034 (USD billion)
  • 8.7. Diarrhea treatment
    • 8.7.1. Global Opioid Market, by Diarrhea treatment, by Region, 2020-2034 (USD billion)
  • 8.8. De-addiction
    • 8.8.1. Global Opioid Market, by De-addiction, by Region, 2020-2034 (USD billion)
  • 8.9. Others
    • 8.9.1. Global Opioid Market, by Others, by Region, 2020-2034 (USD billion)

9. Global Opioid Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Opioid Market Assessment, By Geography, 2020-2034 (USD billion)
  • 9.3. Opioid Market - North America
    • 9.3.1. North America: Opioid Market, by Class, 2020-2034 (USD billion)
    • 9.3.2. North America: Opioid Market, by Product, 2020-2034 (USD billion)
    • 9.3.3. North America: Opioid Market, by Release Type, 2020-2034 (USD billion)
    • 9.3.4. North America: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.3.5. Opioid Market - U.S.
      • 9.3.5.1. U.S.: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.3.5.2. U.S.: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.3.5.3. U.S.: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.3.5.4. U.S.: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.3.6. Opioid Market - Canada
      • 9.3.6.1. Canada: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.3.6.2. Canada: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.3.6.3. Canada: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.3.6.4. Canada: Opioid Market, by Application, 2020-2034 (USD billion)
  • 9.4. Opioid Market - Europe
    • 9.4.1. Europe: Opioid Market, by Class, 2020-2034 (USD billion)
    • 9.4.2. Europe: Opioid Market, by Product, 2020-2034 (USD billion)
    • 9.4.3. Europe: Opioid Market, by Release Type, 2020-2034 (USD billion)
    • 9.4.4. Europe: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.5. Opioid Market - UK
      • 9.4.5.1. UK: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.5.2. UK: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.5.3. UK: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.5.4. UK: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.6. Opioid Market - France
      • 9.4.6.1. France: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.6.2. France: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.6.3. France: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.6.4. France: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.7. Opioid Market - Germany
      • 9.4.7.1. Germany: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.7.2. Germany: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.7.3. Germany: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.7.4. Germany: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.8. Opioid Market - Italy
      • 9.4.8.1. Italy: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.8.2. Italy: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.8.3. Italy: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.8.4. Italy: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.9. Opioid Market - Spain
      • 9.4.9.1. Spain: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.9.2. Spain: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.9.3. Spain: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.9.4. Spain: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.10. Opioid Market - Netherlands
      • 9.4.10.1. Netherlands: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.10.2. Netherlands: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.10.3. Netherlands: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.10.4. Netherlands: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.11. Opioid Market - Russia
      • 9.4.11.1. Russia: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.11.2. Russia: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.11.3. Russia: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.11.4. Russia: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.12. Opioid Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.12.2. Rest of Europe: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.12.3. Rest of Europe: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.12.4. Rest of Europe: Opioid Market, by Application, 2020-2034 (USD billion)
  • 9.5. Opioid Market - Asia Pacific
    • 9.5.1. Asia Pacific: Opioid Market, by Class, 2020-2034 (USD billion)
    • 9.5.2. Asia Pacific: Opioid Market, by Product, 2020-2034 (USD billion)
    • 9.5.3. Asia Pacific: Opioid Market, by Release Type, 2020-2034 (USD billion)
    • 9.5.4. Asia Pacific: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.5. Opioid Market - China
      • 9.5.5.1. China: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.5.2. China: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.5.3. China: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.5.4. China: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.6. Opioid Market - India
      • 9.5.6.1. India: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.6.2. India: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.6.3. India: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.6.4. India: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.7. Opioid Market - Malaysia
      • 9.5.7.1. Malaysia: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.7.2. Malaysia: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.7.3. Malaysia: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.7.4. Malaysia: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.8. Opioid Market - Japan
      • 9.5.8.1. Japan: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.8.2. Japan: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.8.3. Japan: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.8.4. Japan: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.9. Opioid Market - Indonesia
      • 9.5.9.1. Indonesia: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.9.2. Indonesia: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.9.3. Indonesia: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.9.4. Indonesia: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.10. Opioid Market - South Korea
      • 9.5.10.1. South Korea: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.10.2. South Korea: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.10.3. South Korea: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.10.4. South Korea: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.11. Opioid Market - Australia
      • 9.5.11.1. Australia: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.11.2. Australia: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.11.3. Australia: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.11.4. Australia: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.12. Opioid Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.12.2. Rest of Asia Pacific: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.12.3. Rest of Asia Pacific: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.12.4. Rest of Asia Pacific: Opioid Market, by Application, 2020-2034 (USD billion)
  • 9.6. Opioid Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Opioid Market, by Class, 2020-2034 (USD billion)
    • 9.6.2. Middle East & Africa: Opioid Market, by Product, 2020-2034 (USD billion)
    • 9.6.3. Middle East & Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)
    • 9.6.4. Middle East & Africa: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.6.5. Opioid Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.6.5.2. Saudi Arabia: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.6.5.3. Saudi Arabia: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.6.5.4. Saudi Arabia: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.6.6. Opioid Market - UAE
      • 9.6.6.1. UAE: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.6.6.2. UAE: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.6.6.3. UAE: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.6.6.4. UAE: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.6.7. Opioid Market - Israel
      • 9.6.7.1. Israel: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.6.7.2. Israel: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.6.7.3. Israel: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.6.7.4. Israel: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.6.8. Opioid Market - South Africa
      • 9.6.8.1. South Africa: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.6.8.2. South Africa: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.6.8.3. South Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.6.8.4. South Africa: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.6.9. Opioid Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.6.9.2. Rest of Middle East & Africa: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.6.9.3. Rest of Middle East & Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.6.9.4. Rest of Middle East & Africa: Opioid Market, by Application, 2020-2034 (USD billion)
  • 9.7. Opioid Market - Latin America
    • 9.7.1. Latin America: Opioid Market, by Class, 2020-2034 (USD billion)
    • 9.7.2. Latin America: Opioid Market, by Product, 2020-2034 (USD billion)
    • 9.7.3. Latin America: Opioid Market, by Release Type, 2020-2034 (USD billion)
    • 9.7.4. Latin America: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.7.5. Opioid Market - Mexico
      • 9.7.5.1. Mexico: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.7.5.2. Mexico: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.7.5.3. Mexico: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.7.5.4. Mexico: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.7.6. Opioid Market - Brazil
      • 9.7.6.1. Brazil: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.7.6.2. Brazil: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.7.6.3. Brazil: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.7.6.4. Brazil: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.7.7. Opioid Market - Argentina
      • 9.7.7.1. Argentina: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.7.7.2. Argentina: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.7.7.3. Argentina: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.7.7.4. Argentina: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.7.8. Opioid Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.7.8.2. Rest of Latin America: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.7.8.3. Rest of Latin America: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.7.8.4. Rest of Latin America: Opioid Market, by Application, 2020-2034 (USD billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Aurobindo Pharma Limited
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Assertio Therapeutics, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. AbbVie Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Actavis Plc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Amneal Pharmaceuticals LLC
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Boehringer Ingelheim International GmbH
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Cadila Healthcare Limited
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Fresenius Kabi
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Mallinckrodt Pharmaceuticals
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Endo International plc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Johnson & Johnson Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Lupin Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Nesher Pharmaceuticals LLC
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Purdue Pharma L.P.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Pfizer Inc.
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Rhodes Pharmaceuticals L.P.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Sun Pharmaceutical Industries Limited
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development
  • 11.18. Trevena Inc.
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Benchmarking
    • 11.18.4. Recent Development
  • 11.19. Teva Pharmaceutical Industries Ltd.
    • 11.19.1. Company Overview
    • 11.19.2. Financial Performance
    • 11.19.3. Product Benchmarking
    • 11.19.4. Recent Development

List of Tables:

Table 1 Global Opioid Market, by Class, 2020-2034 (USD billion)

Table 2 Global Opioid Market, by Product, 2020-2034 (USD billion)

Table 3 Global Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 4 Global Opioid Market, by Application, 2020-2034 (USD billion)

Table 5 North America: Opioid Market, by Class, 2020-2034 (USD billion)

Table 6 North America: Opioid Market, by Product, 2020-2034 (USD billion)

Table 7 North America: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 8 North America: Opioid Market, by Application, 2020-2034 (USD billion)

Table 9 U.S.: Opioid Market, by Class, 2020-2034 (USD billion)

Table 10 U.S.: Opioid Market, by Product, 2020-2034 (USD billion)

Table 11 U.S.: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 12 U.S.: Opioid Market, by Application, 2020-2034 (USD billion)

Table 13 Canada: Opioid Market, by Class, 2020-2034 (USD billion)

Table 14 Canada: Opioid Market, by Product, 2020-2034 (USD billion)

Table 15 Canada: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 16 Canada: Opioid Market, by Application, 2020-2034 (USD billion)

Table 17 Europe: Opioid Market, by Class, 2020-2034 (USD billion)

Table 18 Europe: Opioid Market, by Product, 2020-2034 (USD billion)

Table 19 Europe: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 20 Europe: Opioid Market, by Application, 2020-2034 (USD billion)

Table 21 UK: Opioid Market, by Class, 2020-2034 (USD billion)

Table 22 UK: Opioid Market, by Product, 2020-2034 (USD billion)

Table 23 UK: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 24 UK: Opioid Market, by Application, 2020-2034 (USD billion)

Table 25 France: Opioid Market, by Class, 2020-2034 (USD billion)

Table 26 France: Opioid Market, by Product, 2020-2034 (USD billion)

Table 27 France: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 28 France: Opioid Market, by Application, 2020-2034 (USD billion)

Table 29 Germany: Opioid Market, by Class, 2020-2034 (USD billion)

Table 30 Germany: Opioid Market, by Product, 2020-2034 (USD billion)

Table 31 Germany: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 32 Germany: Opioid Market, by Application, 2020-2034 (USD billion)

Table 33 Italy: Opioid Market, by Class, 2020-2034 (USD billion)

Table 34 Italy: Opioid Market, by Product, 2020-2034 (USD billion)

Table 35 Italy: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 36 Italy: Opioid Market, by Application, 2020-2034 (USD billion)

Table 37 Spain: Opioid Market, by Class, 2020-2034 (USD billion)

Table 38 Spain: Opioid Market, by Product, 2020-2034 (USD billion)

Table 39 Spain: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 40 Spain: Opioid Market, by Application, 2020-2034 (USD billion)

Table 41 Netherlands: Opioid Market, by Class, 2020-2034 (USD billion)

Table 42 Netherlands: Opioid Market, by Product, 2020-2034 (USD billion)

Table 43 Netherlands: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 44 Netherlands: Opioid Market, by Application, 2020-2034 (USD billion)

Table 45 Russia: Opioid Market, by Class, 2020-2034 (USD billion)

Table 46 Russia: Opioid Market, by Product, 2020-2034 (USD billion)

Table 47 Russia: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 48 Russia: Opioid Market, by Application, 2020-2034 (USD billion)

Table 49 Rest of Europe: Opioid Market, by Class, 2020-2034 (USD billion)

Table 50 Rest of Europe: Opioid Market, by Product, 2020-2034 (USD billion)

Table 51 Rest of Europe: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 52 Rest of Europe: Opioid Market, by Application, 2020-2034 (USD billion)

Table 53 Asia Pacific: Opioid Market, by Class, 2020-2034 (USD billion)

Table 54 Asia Pacific: Opioid Market, by Product, 2020-2034 (USD billion)

Table 55 Asia Pacific: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 56 Asia Pacific: Opioid Market, by Application, 2020-2034 (USD billion)

Table 57 China: Opioid Market, by Class, 2020-2034 (USD billion)

Table 58 China: Opioid Market, by Product, 2020-2034 (USD billion)

Table 59 China: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 60 China: Opioid Market, by Application, 2020-2034 (USD billion)

Table 61 India: Opioid Market, by Class, 2020-2034 (USD billion)

Table 62 India: Opioid Market, by Product, 2020-2034 (USD billion)

Table 63 India: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 64 India: Opioid Market, by Application, 2020-2034 (USD billion)

Table 65 Malaysia: Opioid Market, by Class, 2020-2034 (USD billion)

Table 66 Malaysia: Opioid Market, by Product, 2020-2034 (USD billion)

Table 67 Malaysia: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 68 Malaysia: Opioid Market, by Application, 2020-2034 (USD billion)

Table 69 Japan: Opioid Market, by Class, 2020-2034 (USD billion)

Table 70 Japan: Opioid Market, by Product, 2020-2034 (USD billion)

Table 71 Japan: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 72 Japan: Opioid Market, by Application, 2020-2034 (USD billion)

Table 73 Indonesia: Opioid Market, by Class, 2020-2034 (USD billion)

Table 74 Indonesia: Opioid Market, by Product, 2020-2034 (USD billion)

Table 75 Indonesia: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 76 Indonesia: Opioid Market, by Application, 2020-2034 (USD billion)

Table 77 South Korea: Opioid Market, by Class, 2020-2034 (USD billion)

Table 78 South Korea: Opioid Market, by Product, 2020-2034 (USD billion)

Table 79 South Korea: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 80 South Korea: Opioid Market, by Application, 2020-2034 (USD billion)

Table 81 Australia: Opioid Market, by Class, 2020-2034 (USD billion)

Table 82 Australia: Opioid Market, by Product, 2020-2034 (USD billion)

Table 83 Australia: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 84 Australia: Opioid Market, by Application, 2020-2034 (USD billion)

Table 85 Rest of Asia Pacific: Opioid Market, by Class, 2020-2034 (USD billion)

Table 86 Rest of Asia Pacific: Opioid Market, by Product, 2020-2034 (USD billion)

Table 87 Rest of Asia Pacific: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 88 Rest of Asia Pacific: Opioid Market, by Application, 2020-2034 (USD billion)

Table 89 Middle East & Africa: Opioid Market, by Class, 2020-2034 (USD billion)

Table 90 Middle East & Africa: Opioid Market, by Product, 2020-2034 (USD billion)

Table 91 Middle East & Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 92 Middle East & Africa: Opioid Market, by Application, 2020-2034 (USD billion)

Table 93 Saudi Arabia: Opioid Market, by Class, 2020-2034 (USD billion)

Table 94 Saudi Arabia: Opioid Market, by Product, 2020-2034 (USD billion)

Table 95 Saudi Arabia: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 96 Saudi Arabia: Opioid Market, by Application, 2020-2034 (USD billion)

Table 97 UAE: Opioid Market, by Class, 2020-2034 (USD billion)

Table 98 UAE: Opioid Market, by Product, 2020-2034 (USD billion)

Table 99 UAE: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 100 UAE: Opioid Market, by Application, 2020-2034 (USD billion)

Table 101 Israel: Opioid Market, by Class, 2020-2034 (USD billion)

Table 102 Israel: Opioid Market, by Product, 2020-2034 (USD billion)

Table 103 Israel: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 104 Israel: Opioid Market, by Application, 2020-2034 (USD billion)

Table 105 South Africa: Opioid Market, by Class, 2020-2034 (USD billion)

Table 106 South Africa: Opioid Market, by Product, 2020-2034 (USD billion)

Table 107 South Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 108 South Africa: Opioid Market, by Application, 2020-2034 (USD billion)

Table 109 Rest of Middle East & Africa: Opioid Market, by Class, 2020-2034 (USD billion)

Table 110 Rest of Middle East & Africa: Opioid Market, by Product, 2020-2034 (USD billion)

Table 111 Rest of Middle East & Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 112 Rest of Middle East & Africa: Opioid Market, by Application, 2020-2034 (USD billion)

Table 113 Latin America: Opioid Market, by Class, 2020-2034 (USD billion)

Table 114 Latin America: Opioid Market, by Product, 2020-2034 (USD billion)

Table 115 Latin America: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 116 Latin America: Opioid Market, by Application, 2020-2034 (USD billion)

Table 117 Mexico: Opioid Market, by Class, 2020-2034 (USD billion)

Table 118 Mexico: Opioid Market, by Product, 2020-2034 (USD billion)

Table 119 Mexico: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 120 Mexico: Opioid Market, by Application, 2020-2034 (USD billion)

Table 121 Brazil: Opioid Market, by Class, 2020-2034 (USD billion)

Table 122 Brazil: Opioid Market, by Product, 2020-2034 (USD billion)

Table 123 Brazil: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 124 Brazil: Opioid Market, by Application, 2020-2034 (USD billion)

Table 125 Argentina: Opioid Market, by Class, 2020-2034 (USD billion)

Table 126 Argentina: Opioid Market, by Product, 2020-2034 (USD billion)

Table 127 Argentina: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 128 Argentina: Opioid Market, by Application, 2020-2034 (USD billion)

Table 129 Rest of Latin America: Opioid Market, by Class, 2020-2034 (USD billion)

Table 130 Rest of Latin America: Opioid Market, by Product, 2020-2034 (USD billion)

Table 131 Rest of Latin America: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 132 Rest of Latin America: Opioid Market, by Application, 2020-2034 (USD billion)

List of Figures:

Figure 1. Global Opioid Market, 2020-2034 (USD billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Class

Figure 7. Global Opioid Market, by Class, 2024 & 2034 (USD billion)

Figure 8. Market by Product

Figure 9. Global Opioid Market, by Product, 2024 & 2034 (USD billion)

Figure 10. Market by Release Type

Figure 11. Global Opioid Market, by Release Type, 2024 & 2034 (USD billion)

Figure 12. Market by Application

Figure 13. Global Opioid Market, by Application, 2024 & 2034 (USD billion)

Figure 14. Global Opioid Market Assessment, By Geography, 2020-2034 (USD billion)

  • Figure 15. Strategic Analysis - Global Opioid Market